Upregulation of PIP3-Dependent Rac Exchanger 1 (P-Rex1) Promotes Prostate Cancer Metastasis
暂无分享,去创建一个
M. Hoshino | Jing Zhao | Yan Xie | Y. Tu | Ming-Fong Lin | M. Scofield | F. Dowd | D. Wolff | J. Qin | Bo Wang | M. Lin | Jianbing Qin | Ming-Fong Lin
[1] Dianqing Wu,et al. Lack of a significant role of P-Rex1, a major regulator of macrophage Rac1 activation and chemotaxis, in atherogenesis. , 2008, Prostaglandins & other lipid mediators.
[2] N. Demartines,et al. mTORC2 regulates PGE2-mediated endothelial cell survival and migration. , 2008, Biochemical and biophysical research communications.
[3] P. Steeg,et al. Metastasis: a therapeutic target for cancer , 2008, Nature Clinical Practice Oncology.
[4] A. Smrcka,et al. Small Molecule Disruption of G Protein βγ Subunit Signaling Inhibits Neutrophil Chemotaxis and Inflammation , 2008, Molecular Pharmacology.
[5] M. Thelen,et al. Membrane Translocation of P-Rex1 Is Mediated by G Protein βγ Subunits and Phosphoinositide 3-Kinase* , 2007, Journal of Biological Chemistry.
[6] J. Gutkind,et al. P-Rex1 Links Mammalian Target of Rapamycin Signaling to Rac Activation and Cell Migration* , 2007, Journal of Biological Chemistry.
[7] J. Segall,et al. Cell Motility and Cytoskeletal Regulation in Invasion and Metastasis , 2007, Journal of Mammary Gland Biology and Neoplasia.
[8] G. Xiao,et al. CCR2 expression correlates with prostate cancer progression , 2007, Journal of cellular biochemistry.
[9] J. Condeelis,et al. Regulation of the actin cytoskeleton in cancer cell migration and invasion. , 2007, Biochimica et biophysica acta.
[10] J. Gutkind,et al. G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.
[11] Baolin Zhang,et al. Rac signaling in tumorigenesis and as target for anticancer drug development. , 2006, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[12] M. Schiller. Coupling receptor tyrosine kinases to Rho GTPases--GEFs what's the link. , 2006, Cellular signalling.
[13] M. Simpson,et al. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. , 2006, The American journal of pathology.
[14] John G. Collard,et al. Prognostic relevance of Tiam1 protein expression in prostate carcinomas , 2006, British Journal of Cancer.
[15] P. Casey,et al. A Role for the G12 Family of Heterotrimeric G Proteins in Prostate Cancer Invasion* , 2006, Journal of Biological Chemistry.
[16] Alan V. Smrcka,et al. Differential Targeting of Gßγ-Subunit Signaling with Small Molecules , 2006, Science.
[17] Yan Xie,et al. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells , 2006, Oncogene.
[18] K. Okkenhaug,et al. P-Rex1 Regulates Neutrophil Function , 2005, Current Biology.
[19] D. Yamazaki,et al. Regulation of cancer cell motility through actin reorganization , 2005, Cancer science.
[20] M. Sone,et al. Involvement of a Rac Activator, P-Rex1, in Neurotrophin-Derived Signaling and Neuronal Migration , 2005, The Journal of Neuroscience.
[21] Poonam K Sharma,et al. Decreased expression of e6-associated protein in breast and prostate carcinomas. , 2005, Endocrinology.
[22] P. Finan,et al. Regulation of P-Rex1 by Phosphatidylinositol (3,4,5)-Trisphosphate and Gβγ Subunits* , 2005, Journal of Biological Chemistry.
[23] H. Klocker,et al. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. , 2004, Journal of experimental therapeutics & oncology.
[24] J. Gutkind,et al. P‐REX2, a novel PI‐3‐kinase sensitive Rac exchange factor , 2004, FEBS letters.
[25] E. Yang,et al. Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells , 2004, Oncogene.
[26] Yi Zheng,et al. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Blenis,et al. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.
[28] Meghan E. Minard,et al. The Role of the Guanine Nucleotide Exchange Factor Tiam1 in Cellular Migration, Invasion, Adhesion and Tumor Progression , 2004, Breast Cancer Research and Treatment.
[29] Y. Daaka. G Proteins in Cancer: The Prostate Cancer Paradigm , 2004, Science's STKE.
[30] A. Bookout,et al. Targeting Gβγ Signaling to Inhibit Prostate Tumor Formation and Growth* , 2003, Journal of Biological Chemistry.
[31] J. Gutkind,et al. Rac1 Function Is Required for Src-induced Transformation , 2003, Journal of Biological Chemistry.
[32] F. Mayor,et al. Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation. , 2003, Molecular pharmacology.
[33] Lewis C Cantley,et al. The phosphoinositide 3-kinase pathway. , 2002, Science.
[34] R. Cerione,et al. Signaling to the Rho GTPases: networking with the DH domain , 2002, FEBS letters.
[35] H. Bourne,et al. Gαi Is Not Required for Chemotaxis Mediated by Gi-coupled Receptors* , 1999, The Journal of Biological Chemistry.
[36] S. Bagrodia,et al. Cytoskeletal Reorganization by G Protein-Coupled Receptors Is Dependent on Phosphoinositide 3-Kinase γ, a Rac Guanosine Exchange Factor, and Rac , 1998, Molecular and Cellular Biology.
[37] M. Baggiolini,et al. Two murine homologues of the human chemokine receptor CXCR4 mediating stromal cell‐derived factor 1α activation of Gi2 are differentially expressed in vivo , 1997, European journal of immunology.
[38] K. Ching,et al. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines , 1993, Molecular and Cellular Biochemistry.
[39] A. Smrcka,et al. Small molecule disruption of G protein beta gamma subunit signaling inhibits neutrophil chemotaxis and inflammation. , 2008, Molecular pharmacology.
[40] A. Albini,et al. The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation , 2007, Nature Protocols.
[41] M. Thelen,et al. Membrane translocation of P-Rex1 is mediated by G protein betagamma subunits and phosphoinositide 3-kinase. , 2007, The Journal of biological chemistry.
[42] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[43] Dianqing Wu,et al. Differential targeting of Gbetagamma-subunit signaling with small molecules. , 2006, Science.
[44] M. Mimeault,et al. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. , 2006, Carcinogenesis.
[45] P. Finan,et al. Regulation of P-Rex1 by phosphatidylinositol (3,4,5)-trisphosphate and Gbetagamma subunits. , 2005, The Journal of biological chemistry.
[46] A. Bookout,et al. Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth. , 2003, The Journal of biological chemistry.
[47] P. Hawkins,et al. P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. , 2002, Cell.
[48] A. Bex,et al. Influence of pertussis toxine on local progression and metastasis after orthotopic implantation of the human prostate cancer cell line PC3 in nude mice , 1999, Prostate Cancer and Prostatic Diseases.
[49] H. Bourne,et al. Galphai is not required for chemotaxis mediated by Gi-coupled receptors. , 1999, The Journal of biological chemistry.
[50] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[51] B. Pontz,et al. A study on fibroblast chemotaxis using fibronectin and conditioned medium as chemoattractants. , 1983, European journal of cell biology.